
Celldex ends eczema drug development after mid-stage trial failure
来源:Reuters发布于 2026-11-19
Celldex Therapeutics said on Thursday it would stop developing its experimental drug for eczema after the treatment failed to meet the main and key secondary goals of a mid-stage study.
相关标的:CLDX
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。